|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Steuer CE, El-Deiry M, Parks JR, Higgins
KA and Saba NF: An update on larynx cancer. CA Cancer J Clin.
67:31–50. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ferlito A, Devaney KO, Hunt JL and
Hellquist H: Some considerations on the WHO histological
classification of laryngeal neoplasms. Adv Ther. 36:1511–1517.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wu CW, Dionigi G, Barczynski M, Chiang FY,
Dralle H, Schneider R, Al-Quaryshi Z, Angelos P, Brauckhoff K,
Brooks JA, et al: International neuromonitoring study group
guidelines 2018: Part II: Optimal recurrent laryngeal nerve
management for invasive thyroid cancer-incorporation of surgical,
laryngeal, and neural electrophysiologic data. Laryngoscope. 128
(Suppl 3):S18–S27. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Calkovsky V, Wallenfels P, Calkovska A and
Hajtman A: Laryngeal cancer: 12-year experience of a single center.
Adv Exp Med Biol. 911:9–16. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Laccourreye O, Bonfils P, Malinvaud D,
Ménard M and Giraud P: Survival and laryngeal preservation tradeoff
in advanced laryngeal cancer: From the otorhinolaryngology patient
to the managing physician. Head Neck. 39:1984–1989. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yang G, Lu X and Yuan L: lncRNA: A link
between RNA and cancer. Biochim Biophys Acta. 1839:1097–1109.
2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sang H, Liu H, Xiong P and Zhu M: Long
non-coding RNA functions in lung cancer. Tumour Biol. 36:4027–4037.
2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Teng Y, Kang H and Chu Y: Identification
of an exosomal long noncoding RNA SOX2-OT in plasma as a promising
biomarker for lung squamous cell carcinoma. Genet Test Mol
Biomarkers. 23:235–240. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang Z, Tan M, Chen G, Li Z and Lu X:
lncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma
patients and regulates osteosarcoma cells proliferation and
motility through modulating SOX2. IUBMB Life. 69:867–876.
2017.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Wei CX, Wong H, Xu F, Liu Z, Ran L and
Jiang RD: IRF4-induced upregulation of lncRNA SOX2-OT promotes cell
proliferation and metastasis in cholangiocarcinoma by regulating
SOX2 and PI3K/AKT signaling. Eur Rev Med Pharmacol Sci.
22:8169–8178. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Feng L, Wang R, Lian M, Ma H, He N, Liu H,
Wang H and Fang J: Integrated analysis of long noncoding RNA and
mRNA expression profile in advanced laryngeal squamous cell
carcinoma. PLoS One. 11(e0169232)2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tai Y, Ji Y, Liu F, Zang Y, Xu D, Ma S,
Qin L and Ma J: Long noncoding RNA SOX2-OT facilitates laryngeal
squamous cell carcinoma development by epigenetically inhibiting
PTEN via methyltransferase EZH2. IUBMB Life. 71:1230–1239.
2019.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714.
2009.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Zhang N, Lu C and Chen L: miR-217
regulates tumor growth and apoptosis by targeting the MAPK
signaling pathway in colorectal cancer. Oncol Lett. 12:4589–4597.
2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cybula M, Wieteska L-,
Józefowicz-Korczyńska M, Karbownik MS, Grzelczyk WL and Szemraj J:
New miRNA expression abnormalities in laryngeal squamous cell
carcinoma. Cancer Biomark. 16:559–568. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wang FY, Jia J, Song HH, Jia CM, Chen CB
and Ma J: Icariin protects vascular endothelial cells from
oxidative stress through inhibiting endoplasmic reticulum stress. J
Integr Med. 17:205–212. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Shields EJ, Petracovici AF and Bonasio R:
lncRedibly versatile: Biochemical and biological functions of long
noncoding RNAs. Biochem J. 476:1083–1104. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Xie ZY, Wang P, Wu YF and Shen HY: Long
non-coding RNA: The functional regulator of mesenchymal stem cells.
World J Stem Cells. 11:167–179. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Xu J, Bai J, Zhang X, Lv Y, Gong Y, Liu L,
Zhao H, Yu F, Ping Y, Zhang G, et al: A comprehensive overview of
lncRNA annotation resources. Brief Bioinform. 18:236–249.
2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Sparber P, Filatova A, Khantemirova M and
Skoblov M: The role of long non-coding RNAs in the pathogenesis of
hereditary diseases. BMC Med Genomics. 12 (Suppl
2):S422019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Peng WX, Koirala P and Mo YY:
lncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lu M, Wang C, Chen W, Mao C and Wang J:
miR-654-5p targets GRAP to promote proliferation, metastasis, and
chemoresistance of oral squamous cell carcinoma through Ras/MAPK
signaling. DNA Cell Biol. 37:381–388. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Jin P, Huang Y, Zhu P, Zou Y, Shao T and
Wang O: CircRNA circHIPK3 serves as a prognostic marker to promote
glioma progression by regulating miR-654/IGF2BP3 signaling. Biochem
Biophys Res Commun. 503:1570–1574. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Dhulipala VC, Welshons WV and Reddy CS:
Cell cycle proteins in normal and chemically induced abnormal
secondary palate development: A review. Hum Exp Toxicol.
25:675–682. 2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zatonski T, Ciesielska U, Nowinska K,
Ratajczak-Wielgomas K, Kobierzycki C, Pula B, Podhorska-Okolow M,
Krecicki T and Dziegiel P: Expression of cell cycle-related
proteins p16, p27, p53 and Ki-67 in HPV-positive and -negative
samples of papillomas of the upper respiratory tract. Anticancer
Res. 36:3917–3924. 2016.PubMed/NCBI
|
|
27
|
Lee EF, Harris TJ, Tran S, Evangelista M,
Arulananda S, John T, Ramnac C, Hobbs C, Zhu H, Gunasingh G, et al:
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell
survival. Cell Death Dis. 10(342)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chrysovergis A, S Papanikolaou V, Tsiambas
E, Kikidis D, Maragoudakis P, Ragos V and Kyrodimos E: Caspase
complex in laryngeal squamous cell carcinoma. J BUON. 24:1–4.
2019.PubMed/NCBI
|
|
29
|
Lotfi A, Mohammadi G, Saniee L,
Mousaviagdas M, Chavoshi H and Tavassoli A: Serum level of matrix
metalloproteinase-2 and -9 in patients with laryngeal squamous cell
carcinoma and clinical significance. Asian Pac J Cancer Prev.
16:6749–6751. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Uloza V, Liutkevičius V, Pangonytė D,
Saferis V and Lesauskaitė V: Expression of matrix
metalloproteinases (MMP-2 and MMP-9) in recurrent respiratory
papillomas and laryngeal carcinoma: Clinical and morphological
parallels. Eur Arch Otorhinolaryngol. 268:871–878. 2011.PubMed/NCBI View Article : Google Scholar
|
